Literature DB >> 22029937

Non-genotype-specific role of the hepatitis C virus 5' untranslated region in virus production and in inhibition by interferon.

Yi-Ping Li1, Santseharay Ramirez, Judith M Gottwein, Jens Bukh.   

Abstract

The 5' untranslated region (5'UTR) of hepatitis C virus (HCV) is structured into four domains (I-IV) with numerous genotype-specific nucleotides. It is unknown whether the polymorphisms confer genotype-specific functions to the 5'UTR. Using viable JFH1-based Core-NS2 recombinants, we developed and characterized HCV genotypes 1-7 recombinants with highly diverse 5'UTRs (genotypes 1a and 3a), 2a recombinants (J6/JFH1) with 5'UTR of genotypes 1-6 or with heterotypic chimeric (1a/3a and 3a/1a) 5'UTR domains I, II or III, and 1a recombinants with 5'UTR domain I of genotypes 1-6. All were fully functional in Huh7.5 cells; therefore, the 5'UTR apparently functions in a non-genotype-specific manner in HCV production in vitro. However, adenine at the 5'-terminus was required. We demonstrated that J6/JFH1 with 5'UTR of genotypes 1-6 responded similarly to interferon-α2b. This study provides novel insight into the role of the 5'UTR in the HCV life cycle and facilitates HCV basic research and testing of 5'UTR-targeting antivirals. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22029937     DOI: 10.1016/j.virol.2011.10.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.

Authors:  Yi-Ping Li; Santseharay Ramirez; Sanne B Jensen; Robert H Purcell; Judith M Gottwein; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

2.  miR-122 and Ago interactions with the HCV genome alter the structure of the viral 5' terminus.

Authors:  Jasmin Chahal; Luca F R Gebert; Hin Hark Gan; Edna Camacho; Kristin C Gunsalus; Ian J MacRae; Selena M Sagan
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

3.  Inhibition of hepatitis C virus replication by intracellular delivery of multiple siRNAs by nanosomes.

Authors:  Partha K Chandra; Anup K Kundu; Sidhartha Hazari; Sruti Chandra; Lili Bao; Tara Ooms; Gilbert F Morris; Tong Wu; Tarun K Mandal; Srikanta Dash
Journal:  Mol Ther       Date:  2012-05-22       Impact factor: 11.454

4.  Identification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.

Authors:  Stéphanie B N Serre; Henrik B Krarup; Jens Bukh; Judith M Gottwein
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

5.  Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.

Authors:  Judith M Gottwein; Sanne B Jensen; Stéphanie B N Serre; Lubna Ghanem; Troels K H Scheel; Tanja B Jensen; Henrik Krarup; Nathalie Uzcategui; Lotte S Mikkelsen; Jens Bukh
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

Review 6.  New hepatitis C virus drug discovery strategies and model systems.

Authors:  Snawar Hussain; Naina Barretto; Susan L Uprichard
Journal:  Expert Opin Drug Discov       Date:  2012-08-04       Impact factor: 6.098

7.  A novel strategy to develop a robust infectious hepatitis C virus cell culture system directly from a clinical isolate.

Authors:  Jie Lu; Yu Xiang; Wanyin Tao; Qingchao Li; Na Wang; Yongfeng Gao; Xiaogang Xiang; Qing Xie; Jin Zhong
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

8.  Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.

Authors:  Yi-Ping Li; Santseharay Ramirez; Judith M Gottwein; Troels K H Scheel; Lotte Mikkelsen; Robert H Purcell; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-30       Impact factor: 11.205

9.  Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B In Cellulo.

Authors:  Philipp Schult; Maren Nattermann; Chris Lauber; Stefan Seitz; Volker Lohmann
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

10.  Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.

Authors:  Long V Pham; Santseharay Ramirez; Thomas H R Carlsen; Yi-Ping Li; Judith M Gottwein; Jens Bukh
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.